1105662-99-4 Usage
General Description
"(3-amino-oxetan-3-yl)-acetic acid methyl ester" is a chemical compound that consists of an amino group attached to a five-membered oxetane ring, which is in turn connected to a carboxylic acid and a methyl ester group. (3-amino-oxetan-3-yl)-acetic acid methyl ester is of interest in the field of medicinal chemistry and drug development due to its unique structure and potential biological activities. It may have applications as a building block in the synthesis of pharmaceuticals or as a potential drug candidate itself. Further research is needed to fully understand the properties and potential uses of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1105662-99-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,5,6,6 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1105662-99:
(9*1)+(8*1)+(7*0)+(6*5)+(5*6)+(4*6)+(3*2)+(2*9)+(1*9)=134
134 % 10 = 4
So 1105662-99-4 is a valid CAS Registry Number.
1105662-99-4Relevant articles and documents
Furo-3-carboxamide derivatives and methods of use
-
Page/Page column 102; 104, (2017/10/24)
Compounds of formula (I) and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R1, Z1, Z2, and n are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by Tropomysin receptor kinases (Trk). Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.
HETEROCYCLIC COMPOUNDS USEFUL AS MK2 INHIBITORS
-
Page/Page column 51, (2009/03/07)
The present invention describes tetracyclic compounds of formula (IA) or (IB), wherein the symbols R, X, A, Y, R2, R3 and D are as defined in the specification, their use in the treatment of certain diseases, e.g. depending on MK-2 or TNF activity, and wa
